Invention Grant
- Patent Title: Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
-
Application No.: US16188238Application Date: 2018-11-12
-
Publication No.: US10941113B2Publication Date: 2021-03-09
- Inventor: Koen Vandyck , Stefaan Julien Last , Pierre Jean-Marie Bernard Raboisson
- Applicant: Janssen Sciences Ireland UC
- Applicant Address: IE Little Island, Co Cork
- Assignee: Janssen Sciences Ireland UC
- Current Assignee: Janssen Sciences Ireland UC
- Current Assignee Address: IE Little Island, Co Cork
- Priority: EP13157232 20130228,EP13170069 20130531
- Main IPC: C07C311/37
- IPC: C07C311/37 ; A61K31/18 ; C07C311/16 ; C07C311/17 ; C07C311/18 ; C07C311/19 ; C07C317/28 ; A61K45/06 ; A61K31/27 ; A61K31/277
Abstract:
Inhibitors of HBV replication of Formula (I) including stereochemically isomeric forms, salts, hydrates and solvates thereof, wherein R1, R2, R3 and R4 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
Public/Granted literature
- US20190077749A1 SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B Public/Granted day:2019-03-14
Information query
